Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma

NCT00300521 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Liver Transplantation

Interventions

GENETIC: ADV-TK (adenovirus-thymidine kinase enzyme) gene therapy

Sponsor

Beijing Chao Yang Hospital

Collaborators

[object Object]
[object Object]